ReviewFrontiers in clinical diabetes and healthcare2025

New frontiers in type I diabetes treatment: the impact of mesenchymal stromal cells on long-term complications.

Deeptha Bejugam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.